TickerFactsScreenerDevelopers

Inhibitor Therapeutics, Inc. (INTI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$464.3K2013: -$1.22M2017: -$2.91M2018: -$3.71M2019: -$2.71M2020: -$825.4K2021: -$220.4K2022: $11.74M2023: -$2.70M2024: -$3.23M2025: -$3.23M-$3.23M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.23M+0.1%
2024-$3.23M-19.7%
2023-$2.70M-123.0%
2022$11.74M+5426.2%
2021-$220.4K+73.3%
2020-$825.4K+69.5%
2019-$2.71M+27.0%
2018-$3.71M-27.3%
2017-$2.91M—
2013-$1.22M-163.6%
2012-$464.3K—